US regulators recommend 'pause' in use of J&J vaccine over blood clot fears

Tuesday April 13 2021
Johnson & Johnson Covid vaccine

Vials with Covid-19 Vaccine stickers attached and syringes with the logo of US pharmaceutical company Johnson & Johnson in this photo taken on November 17, 2020. PHOTO | AFP



Top US health authorities have recommended a "pause" in the use of the Johnson & Johnson Covid-19 vaccine "out of an abundance of caution" as they investigate any links between it and blood clots, a regulator said Tuesday.

The US Food and Drug Administration and the Centers for Disease Control are assessing the "potential significance" of six reported cases of a rare blood clot in patients who have received the shot, the FDA tweeted.

"Until that process is complete, we are recommending this pause," it said.